Preliminary sales figures for February 2026 from Swedish nutritional supplements provider Zinzino AB (ticker: ZINZ B) reveal a company in transition, powered by explosive growth in the Americas. The group’s total revenue advanced by 32 percent to 286.3 million Swedish kronor (SEK), though performance varied sharply across its global markets.
A Strong Start to the Year
Cumulatively, Zinzino’s revenue for the first two months of 2026 reached 568.6 million SEK. This represents a 26 percent increase compared to the same period last year. The company’s share price was quoted at approximately 151.80 SEK following the release of these figures.
Regional Performance: A Tale of Two Trends
The geographic breakdown of February’s sales highlights a strategic shift that appears to be paying off in new territories while weighing on some established ones.
High-Growth Regions:
* North America emerged as the standout performer, with revenue skyrocketing 108 percent to 67.5 million SEK. For the January-February period, this market contributed 109.9 million SEK, more than doubling year-over-year.
* Central Europe also delivered robust growth, adding 43 percent to reach 81.8 million SEK. Its two-month total came to 171.0 million SEK, a 35 percent gain.
* South America posted a dramatic 200 percent increase to 3.6 million SEK, albeit from a very low base.
* South and West Europe saw revenue climb 33 percent to 50.2 million SEK.
* Even the smaller African market grew 47 percent to 2.2 million SEK.
Should investors sell immediately? Or is it worth buying Zinzino ABries B?
Regions Facing Headwinds:
In contrast, several traditional strongholds experienced a contraction in February.
* Revenue in the Nordic countries declined by 9 percent to 22.5 million SEK.
* Eastern Europe fell 10 percent to 26.2 million SEK.
* The Asia-Pacific region decreased by 6 percent to 18.6 million SEK.
* The Baltic region contracted by 3 percent to 8.5 million SEK.
Subsidiary Performance
Zinzino’s pharmaceutical subsidiary, Faun Pharma, reported a 24 percent increase in external revenue, which totaled 5.2 million SEK for the month.
The preliminary data underscores the impact of Zinzino’s geographical realignment. The strategy is clearly fueling dynamic expansion in key markets, though this growth is coinciding with a loss of momentum in several of its core regions.
Ad
Zinzino ABries B Stock: Buy or Sell?! New Zinzino ABries B Analysis from March 5 delivers the answer:
The latest Zinzino ABries B figures speak for themselves: Urgent action needed for Zinzino ABries B investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 5.
Zinzino ABries B: Buy or sell? Read more here...
